http://hl7.org/fhir/uv/ebm/PublicationRecord/179615
type: PublicationRecord
resource definition: 1.0
resource definition: .0
node role: treeRoot
id:
  v: 179615
meta:
  version id:
    v: 22
  last updated:
    v: 2026-06-26T20:08:05.918Z
  profile:
    v: http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation
    l: journal-article-citation
language:
  v: en
text:
  status:
    v: extensions
  div:
    v: Generated Narrative: PublicationRecord 179615 version: 22; Last updated: 2026-06-26 20:08:05+0000 Profile: JournalArticleCitation ArtifactPublicationStatus: Active url: https://fevir.net/resources/PublicationRecord/179615 identifier: FEvIR Object Identifier/179615, https://pubmed.ncbi.nlm.nih.gov/23306100 title: 23306100 Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial. status: Active author: Computable Publishing®: MEDLINE-to-FEvIR Converter: publisher: Computable Publishing LLC contact: support@computablepublishing.com description: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide. UseContexts - Code Value[x] * Citation Classification Type: fevir-platform-use (FEvIR Platform Use) Medline Base copyright: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). approvalDate: 2013-03-25 lastReviewDate: 2022-12-08 classification type: Citation Source classifier: MEDLINE classification type: MEDLINE Citation Owner classifier: National Library of Medicine, Index Section currentState: Medline Citation Status of Medline, PubMed PublicationStatus of ppublish statusDate activity: PubMed Pubstatus of Entrez period: ?? --> 2013-01-12 06:00:00+0000 statusDate activity: PubMed Pubstatus of Pubmed period: ?? --> 2013-01-12 06:00:00+0000 statusDate activity: PubMed Pubstatus of Medline period: ?? --> 2013-03-26 06:00:00+0000 citedArtifact identifier: https://pubmed.ncbi.nlm.nih.gov/23306100, https://doi.org/10.1016/S1470-2045(12)70560-0, pii/S1470-2045(12)70560-0 relatedIdentifier: <a href="http://terminology.hl7.org/7.3.0/NamingSystem-ClinicalTrials-Gov.html" title="The U.S. National Institutes of Health, Department of Health and Human Services, through its N…
contained: Practitioner
  id:
    v: contributor0
  name:
    family:
      v: Gravis
    given:
      v: Gwenaelle
contained: Practitioner
  id:
    v: contributor1
  name:
    family:
      v: Fizazi
    given:
      v: Karim
contained: Practitioner
  id:
    v: contributor2
  name:
    family:
      v: Joly
    given:
      v: Florence
contained: Practitioner
  id:
    v: contributor3
  name:
    family:
      v: Oudard
    given:
      v: Stéphane
contained: Practitioner
  id:
    v: contributor4
  name:
    family:
      v: Priou
    given:
      v: Franck
contained: Practitioner
  id:
    v: contributor5
  name:
    family:
      v: Esterni
    given:
      v: Benjamin
contained: Practitioner
  id:
    v: contributor6
  name:
    family:
      v: Latorzeff
    given:
      v: Igor
contained: Practitioner
  id:
    v: contributor7
  name:
    family:
      v: Delva
    given:
      v: Remy
contained: Practitioner
  id:
    v: contributor8
  name:
    family:
      v: Krakowski
    given:
      v: Ivan
contained: Practitioner
  id:
    v: contributor9
  name:
    family:
      v: Laguerre
    given:
      v: Brigitte
contained: Practitioner
  id:
    v: contributor10
  name:
    family:
      v: Rolland
    given:
      v: Fréderic
contained: Practitioner
  id:
    v: contributor11
  name:
    family:
      v: Théodore
    given:
      v: Christine
contained: Practitioner
  id:
    v: contributor12
  name:
    family:
      v: Deplanque
    given:
      v: Gael
contained: Practitioner
  id:
    v: contributor13
  name:
    family:
      v: Ferrero
    given:
      v: Jean Marc
contained: Practitioner
  id:
    v: contributor14
  name:
    family:
      v: Pouessel
    given:
      v: Damien
contained: Practitioner
  id:
    v: contributor15
  name:
    family:
      v: Mourey
    given:
      v: Loïc
contained: Practitioner
  id:
    v: contributor16
  name:
    family:
      v: Beuzeboc
    given:
      v: Philippe
contained: Practitioner
  id:
    v: contributor17
  name:
    family:
      v: Zanetta
    given:
      v: Sylvie
contained: Practitioner
  id:
    v: contributor18
  name:
    family:
      v: Habibian
    given:
      v: Muriel
contained: Practitioner
  id:
    v: contributor19
  name:
    family:
      v: Berdah
    given:
      v: Jean François
contained: Practitioner
  id:
    v: contributor20
  name:
    family:
      v: Dauba
    given:
      v: Jerome
contained: Practitioner
  id:
    v: contributor21
  name:
    family:
      v: Baciuchka
    given:
      v: Marjorie
contained: Practitioner
  id:
    v: contributor22
  name:
    family:
      v: Platini
contained: ArtifactAssessment

v: Christian

Practitioner
id:
  v: contributor23
name:
  family:
    v: Linassier
  given:
    v: Claude

Practitioner
id:
  v: contributor24
name:
  family:
    v: Labourey
  given:
    v: Jean Luc

Practitioner
id:
  v: contributor25
name:
  family:
    v: Machiels
  given:
    v: Jean Pascal

Practitioner
id:
  v: contributor26
name:
  family:
    v: El Kouri
  given:
    v: Claude

Practitioner
id:
  v: contributor27
name:
  family:
    v: Ravaud
  given:
    v: Alain

Practitioner
id:
  v: contributor28
name:
  family:
    v: Suc
  given:
    v: Etienne

Practitioner
id:
  v: contributor29
name:
  family:
    v: Eymard
  given:
    v: Jean Christophe

Practitioner
id:
  v: contributor30
name:
  family:
    v: Hasbini
  given:
    v: Ali

Practitioner
id:
  v: contributor31
name:
  family:
    v: Bousquet
  given:
    v: Guilhem

Practitioner
id:
  v: contributor32
name:
  family:
    v: Soulie
  given:
    v: Michel

ArtifactAssessment
id:
  v: meshHeading0
artifact: Reference
  l: #
  reference:
    v: #
  type:
    v: PublicationRecord
    l: PublicationRecord
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: D000368
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000368
      display:
        v: Aged
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: D000726
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000726
      display:
        v: Androgen Antagonists
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
  component:
    type:
      text:
        v: qualifier
    classifier: Q000008
  component:
    type:
      text:
        v: qualifier
    classifier: Q000627
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: D000971
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000971
      display:
        v: Antineoplastic Combined Chemotherapy Protocols
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
  component:
    type:
      text:
        v: qualifier
    classifier: Q000627
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: D018572
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D018572
      display:
        v: Disease-Free Survival
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: http://id.nlm.nih.gov/mesh/D000077143
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D000077143
      display:
        v: Docetaxel
      user selected:
        v: false
  free to share:
    v: true
  component:
    type:
      text:
        v: qualifier
    classifier:
      text:
        v: is not a major topic
content:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
        l: cited-artifact-classification-type
      code:
        v: mesh-heading
      display:
        v: MeSH heading
    text:
      v: components (if present) include qualifier codings
  classifier: D006801
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D006801

v: Q000008

v: administration & dosage

v: is Major topic

system:
  v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
  l: Thesaurus.owl
code:
  v: C49487
display:
  v: No

v: Q000627

v: therapeutic use

v: is Major topic

system:
  v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
  l: Thesaurus.owl
code:
  v: C49488
display:
  v: Yes

v: Q000627

v: therapeutic use

v: is Major topic

system:
  v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
  l: Thesaurus.owl
code:
  v: C49488
display:
  v: Yes

v: Humans

v: false

v: true

type:
  text:
    v: qualifier
classifier:
  text:
    v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier: D008297
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008297
    display:
      v: Male
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier: D008875
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D008875
    display:
      v: Middle Aged
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier: D009919
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D009919
    display:
      v: Orchiectomy
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier: D011471
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D011471
    display:
      v: Prostatic Neoplasms
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier: Q000188
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000188
      display:
        v: drug therapy
  component:
    type:
      text:
        v: is Major topic
component:
  type:
    text:
      v: qualifier
  classifier: Q000401
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000401
      display:
        v: mortality
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

v: C49487

v: No

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
  text:
    v: components (if present) include qualifier codings
classifier: D043823
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D043823
    display:
      v: Taxoids
    user selected:
      v: false
free to share:
  v: true
component:
  type:
    text:
      v: qualifier
  classifier:
    text:
      v: is not a major topic
component:
  type:
    text:
      v: qualifier
  classifier: Q000008
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000008
      display:
        v: administration & dosage
  component:
    type:
      text:
        v: is Major topic
component:
  type:
    text:
      v: qualifier
  classifier: Q000627
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: Q000627
      display:
        v: therapeutic use
  component:
    type:
      text:
        v: is Major topic

v: C49488

v: Yes

v: C49488

v: Yes

url:
  v: http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status
  l: artifact-publication-status
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-status-type
      l: cited-artifact-status-type
    code:
      v: active
    display:
      v: Active

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: ACSN
    display:
      v: Accession ID
  text:
    v: FEvIR Object Identifier
system:
  v: https://fevir.net/FOI
  l: FOI
value:
  v: 179615
assigner:
  display:
    v: Computable Publishing LLC

system:
  v: https://pubmed.ncbi.nlm.nih.gov
  l: pubmed.ncbi.nlm.nih.gov
value:
  v: 23306100

v: 23306100 Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

v: active

name:
  v: Computable Publishing®: MEDLINE-to-FEvIR Converter

v: Computable Publishing LLC

telecom:
  system:
    v: email

v: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.

code:
  system:
    v: http://terminology.hl7.org/CodeSystem/citation-classification-type
    l: citation-classification-type
  code:
    v: fevir-platform-use
  display:
    v: FEvIR Platform Use
value: CodeableConcept
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: medline-base
    display:
      v: Medline Base
    user selected:
      v: false

v: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

v: 2013-03-25

v: 2022-12-08

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: citation-source
    display:
      v: Citation Source
classifier:
  text:
    v: MEDLINE

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-classification-type
      l: citation-classification-type
    code:
      v: medline-owner
    display:
      v: MEDLINE Citation Owner
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value
      l: owner value
    code:
      v: NLM
    display:
      v: National Library of Medicine, Index Section
    user selected:
      v: false

coding:
  system:
    v: http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type
    l: publicationrecord-status-type
  code:
    v: medline-medline
  display:
    v: Medline Citation Status of Medline

coding:
  system:
    v: http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type
    l: publicationrecord-status-type
  code:
    v: pubmed-publication-status-ppublish
  display:
    v: PubMed PublicationStatus of ppublish

activity:
  coding:
    system:
      v: http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type
      l: publicationrecord-status-type
    code:
      v: pubmed-pubstatus-entrez
    display:
      v: PubMed Pubstatus of Entrez
period:
  end:
    v: 2013-01-12T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type
      l: publicationrecord-status-type
    code:
      v: pubmed-pubstatus-pubmed
    display:
      v: PubMed Pubstatus of Pubmed
period:
  end:
    v: 2013-01-12T06:00:00.000Z

activity:
  coding:
    system:
      v: http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type
      l: publicationrecord-status-type
    code:
      v: pubmed-pubstatus-medline
    display:
      v: PubMed Pubstatus of Medline
period:
  end:
    v: 2013-03-26T06:00:00.000Z

identifier:
  system:
    v: https://pubmed.ncbi.nlm.nih.gov
    l: pubmed.ncbi.nlm.nih.gov
  value:
    v: 23306100
identifier:
  system:
    v: https://doi.org
    l: doi.org
  value:
    v: 10.1016/S1470-2045(12)70560-0
identifier:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/v2-0203
        l: v2-0203
      code:
        v: ACSN
      display:
        v: Accession ID
    text:
      v: pii
  value:
    v: S1470-2045(12)70560-0
related identifier:
  system:
    v: https://clinicaltrials.gov/nctid
    l: nctid
  value:
    v: NCT00104715
  assigner:
    display:
      v: ClinicalTrials.gov
title:
  type:
    coding:
      system:
        v: http://hl7.org/fhir/title-type
        l: title-type
      code:
        v: primary
      display:
        v: Primary title
  language:
    v: en
  text:
    v: Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
abstract:
  type:
    coding:
      system:
        v: http://hl7.org/fhir/cited-artifact-abstract-type
        l: cited-artifact-abstract-type
      code:
        v: primary-human-use
      display:
        v: Primary human use
  text:
    v: **BACKGROUND:** Early chemotherapy might improve the overall outcomes of patients with metastatic non-castrate (ie, hormone-sensitive) prostate cancer. We investigated the effects of the addition of docetaxel to androgen-deprivation therapy (ADT) for patients with metastatic non-castrate prostate cancer. **METHODS:** In this randomised, open-label, phase 3 study, we enrolled patients in 29 centres in France and one in Belgium. Eligible patients were older than 18 years and had histologically confirmed adenocarcinoma of the prostate and radiologically proven metastatic disease; a Karnofsky score of at least 70%; a life expectancy of at least 3 months; and adequate hepatic, haematological, and renal function. They were randomly assigned to receive to ADT (orchiectomy or luteinising hormone-releasing hormone agonists, alone or combined with non-steroidal antiandrogens) alone or in combination with docetaxel (75 mg/m(2) intravenously on the first day of each 21-day cycle; up to nine cycles). Patients were randomised in a 1:1 ratio, with dynamic minimisation to minimise imbalances in previous systemic treatment with ADT, chemotherapy for local disease or isolated rising concentration of serum prostate-specific antigen, and Glass risk groups. Patients, physicians, and data analysts were not masked to treatment allocation. The primary endpoint was overall survival. Efficacy analyses were done by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00104715. **FINDINGS:** Between Oct 18, 2004, and Dec 31, 2008, 192 patients were randomly allocated to receive ADT plus docetaxel and 193 to receive ADT alone. Median follow-up was 50 months (IQR 39-63). Median overall survival was 58·9 months (95% CI 50·8-69·1) in the group given ADT plus docetaxel and 54·2 months (42·2-not reached) in that given ADT alone (hazard ratio 1·01, 95% CI 0·75-1·36). 72 serious adverse events were reported in the group given ADT plus docetaxel, of which the most frequent we…
  copyright:
    v: Copyright © 2013 Elsevier Ltd. All rights reserved.
relates to:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-relationship-type
        l: artifact-relationship-type
      code:
        v: comment-in
      display:
        v: Has Comment In
  classifier: D016420
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Lancet Oncol. 2013 Feb;14(2):104-5. doi: 10.1016/S1470-2045(12)70591-0.
  target: Uri
    v: https://pubmed.ncbi.nlm.nih.gov/23306099/
    l: https://pubmed.ncbi.nlm.nih.gov/23306099/
relates to:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-relationship-type
        l: artifact-relationship-type
      code:
        v: comment-in
      display:
        v: Has Comment In
  classifier: D016420
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Nat Rev Urol. 2013 Mar;10(3):123. doi: 10.1038/nrurol.2013.12.
  target: Uri
    v: https://pubmed.ncbi.nlm.nih.gov/23358518/
    l: https://pubmed.ncbi.nlm.nih.gov/23358518/
relates to:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-relationship-type
        l: artifact-relationship-type
      code:
        v: comment-in
      display:
        v: Has Comment In
  classifier: D016420
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: J Urol. 2013 Dec;190(6):2094. doi: 10.1016/j.juro.2013.08.104.
  target: Uri
    v: https://pubmed.ncbi.nlm.nih.gov/24209521/
    l: https://pubmed.ncbi.nlm.nih.gov/24209521/
relates to:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-relationship-type
        l: artifact-relationship-type
      code:
        v: comment-in
      display:
        v: Has Comment In
  classifier: D016420
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Urol Oncol. 2013 Nov;31(8):1845. doi: 10.1016/j.urolonc.2013.08.011.
  target: Uri
    v: https://pubmed.ncbi.nlm.nih.gov/24210084/
    l: https://pubmed.ncbi.nlm.nih.gov/24210084/
relates to:
  type:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/artifact-relationship-type
        l: artifact-relationship-type
      code:
        v: comment-in
      display:
        v: Has Comment In
  classifier: D016420
    coding:
      system:
        v: https://www.nlm.nih.gov/mesh
        l: mesh
      code:
        v: D016420
      display:
        v: Comment
      user selected:
        v: false
  citation:
    v: Actas Urol Esp. 2017 Jul - Aug;41(6):347-351. doi: 10.1016/j.acuro.2016.11.008.
  target: Uri
    v: https://pubmed.ncbi.nlm.nih.gov/28214037/
    l: https://pubmed.ncbi.nlm.nih.gov/28214037/
publication form:
  published in:
    identifier:
      system:
        v: https://portal.issn.org
        l: portal.issn.org
      value:
        v: 1474-5488
    identifier:
      system:
        v: https://www.issn.org/services/online-services/access-to-the-ltwa/
        l: access-to-the-ltwa

v: D020492

v: Periodical

system:
  v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn
  l: issn
code:
  v: Electronic
display:
  v: Electronic

v: Electronic ISSN Type

system:
  v: http://terminology.hl7.org/CodeSystem/v2-0203
  l: v2-0203
code:
  v: XX
display:
  v: Organization identifier

v: ISOAbbreviation

v: Lancet Oncol

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: XX
    display:
      v: Organization identifier
  text:
    v: ISSN Linking
system:
  v: https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/
  l: the-issn-l-for-publications-on-multiple-media
value:
  v: 1470-2045

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: XX
    display:
      v: Organization identifier
  text:
    v: Medline Title Abbreviation
system:
  v: https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html
  l: contructitleabbre.html
value:
  v: Lancet Oncol

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v2-0203
      l: v2-0203
    code:
      v: XX
    display:
      v: Organization identifier
  text:
    v: NLM Unique ID
system:
  v: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
  l: https://locatorplus.gov/cgi-bin/Pwebrecon.cgi
value:
  v: 100957246

v: The Lancet. Oncology

v: England

coding:
  system:
    v: http://terminology.hl7.org/CodeSystem/cited-medium
    l: cited-medium
  code:
    v: internet
  display:
    v: Internet

v: 14

v: 2

v: 2013-02

v: 2013-Feb

v: 149-58

cited medium:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-medium
      l: cited-medium
    code:
      v: internet-without-issue
    display:
      v: Internet without issue
article date:
  v: 2013-01-08

classifier:
  coding:
    system:
      v: http://hl7.org/fhir/artifact-url-classifier
      l: artifact-url-classifier
    code:
      v: abstract
    display:
      v: Abstract
url:
  v: https://pubmed.ncbi.nlm.nih.gov/23306100/
  l: https://pubmed.ncbi.nlm.nih.gov/23306100/

classifier:
  coding:
    system:
      v: http://hl7.org/fhir/artifact-url-classifier
      l: artifact-url-classifier
    code:
      v: doi-based
    display:
      v: DOI Based
url:
  v: https://doi.org/10.1016/S1470-2045(12)70560-0
  l: S1470-2045(12)70560-0

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: publishing-model
    display:
      v: Publishing Model
    user selected:
      v: false
classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: Print-Electronic
    display:
      v: Print Electronic
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: chemical
    display:
      v: Chemical
    user selected:
      v: false
classifier: D000726
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D000726
    display:
      v: Androgen Antagonists
    user selected:
      v: false
classifier: D043823
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D043823
    display:
      v: Taxoids
    user selected:
      v: false
classifier: http://id.nlm.nih.gov/mesh/D000077143
  coding:
    system:
      v: https://www.cas.org/support/documentation/chemical-substances
      l: chemical-substances
    code:
      v: 15H5577CQD
    user selected:
      v: false
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D000077143
    display:
      v: Docetaxel
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: mesh-heading
    display:
      v: MeSH heading
artifact assessment:
  l: meshHeading0
  reference:
    v: #meshHeading0
  type:
    v: ArtifactAssessment
    l: ArtifactAssessment

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: publication-type
    display:
      v: Publication type
classifier: D017428
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D017428
    display:
      v: Clinical Trial, Phase III
    user selected:
      v: false
classifier: D016428
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
classifier: D016449
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D016449
    display:
      v: Randomized Controlled Trial
    user selected:
      v: false
classifier: D013485
  coding:
    system:
      v: https://www.nlm.nih.gov/mesh
      l: mesh
    code:
      v: D013485
    display:
      v: Research Support, Non-U.S. Gov't
    user selected:
      v: false

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: knowledge-artifact-type
    display:
      v: Knowledge Artifact Type
    user selected:
      v: false
classifier:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/citation-artifact-classifier
      l: citation-artifact-classifier
    code:
      v: D016428
    display:
      v: Journal Article
    user selected:
      v: false
artifact assessment:
  display:
    v: Classifier added by Computable Publishing LLC

type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type
      l: cited-artifact-classification-type
    code:
      v: citation-subset
    display:
      v: Citation subset
    user selected:
      v: false
classifier:
  coding:
    system:
      v: https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset
      l: citationsubset
    code:
      v: IM
    display:
      v: IM
    user selected:
      v: false

complete:
  v: true
entry:
  contributor:
    l: contributor0
    reference:
      v: #contributor0
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Gravis G
  forename initials:
    v: G
  affiliation:
    display:
      v: Medical Oncology and Biostatistics, Institut Paoli-Calmettes, Marseille, France. gravisg@ipc.unicancer.fr
entry:
  contributor:
    l: contributor1
    reference:
      v: #contributor1
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Fizazi K
  forename initials:
    v: K
entry:
  contributor:
    l: contributor2
    reference:
      v: #contributor2
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Joly F
  forename initials:
    v: F
entry:
  contributor:
    l: contributor3
    reference:
      v: #contributor3
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Oudard S
  forename initials:
    v: S
entry:
  contributor:
    l: contributor4
    reference:
      v: #contributor4
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Priou F
  forename initials:
    v: F
entry:
  contributor:
    l: contributor5
    reference:
      v: #contributor5
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Esterni B
  forename initials:
    v: B
entry:
  contributor:
    l: contributor6
    reference:
      v: #contributor6
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Latorzeff I
  forename initials:
    v: I
entry:
  contributor:
    l: contributor7
    reference:
      v: #contributor7
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Delva R
  forename initials:
    v: R
entry:
  contributor:
    l: contributor8
    reference:
      v: #contributor8
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Krakowski I
  forename initials:
    v: I
entry:
  contributor:
    l: contributor9
    reference:
      v: #contributor9
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Laguerre B
  forename initials:
    v: B
entry:
  contributor:
    l: contributor10
    reference:
      v: #contributor10
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Rolland F
  forename initials:
    v: F
entry:
  contributor:
    l: contributor11
    reference:
      v: #contributor11
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Théodore C
  forename initials:
    v: C
entry:
  contributor:
    l: contributor12
    reference:
      v: #contributor12
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Deplanque G
  forename initials:
    v: G
entry:
  contributor:
    l: contributor13
    reference:
      v: #contributor13
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Ferrero JM
  forename initials:
    v: JM
entry:
  contributor:
    l: contributor14
    reference:
      v: #contributor14
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Pouessel D
  forename initials:
    v: D
entry:
  contributor:
    l: contributor15
    reference:
      v: #contributor15
    type:
      v: Practitioner
      l: Practitioner
    display:
      v: Mourey L
  forename initials:
    v: L
entry:
  contributor:
    l: contributor16
    reference:
      v: #contributor16

v: Practitioner
l: Practitioner

v: Beuzeboc P

v: P

contributor:
  l: contributor17
  reference:
    v: #contributor17
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Zanetta S
forename initials:
  v: S

contributor:
  l: contributor18
  reference:
    v: #contributor18
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Habibian M
forename initials:
  v: M

contributor:
  l: contributor19
  reference:
    v: #contributor19
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Berdah JF
forename initials:
  v: JF

contributor:
  l: contributor20
  reference:
    v: #contributor20
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Dauba J
forename initials:
  v: J

contributor:
  l: contributor21
  reference:
    v: #contributor21
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Baciuchka M
forename initials:
  v: M

contributor:
  l: contributor22
  reference:
    v: #contributor22
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Platini C
forename initials:
  v: C

contributor:
  l: contributor23
  reference:
    v: #contributor23
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Linassier C
forename initials:
  v: C

contributor:
  l: contributor24
  reference:
    v: #contributor24
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Labourey JL
forename initials:
  v: JL

contributor:
  l: contributor25
  reference:
    v: #contributor25
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Machiels JP
forename initials:
  v: JP

contributor:
  l: contributor26
  reference:
    v: #contributor26
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: El Kouri C
forename initials:
  v: C

contributor:
  l: contributor27
  reference:
    v: #contributor27
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Ravaud A
forename initials:
  v: A

contributor:
  l: contributor28
  reference:
    v: #contributor28
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Suc E
forename initials:
  v: E

contributor:
  l: contributor29
  reference:
    v: #contributor29
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Eymard JC
forename initials:
  v: JC

contributor:
  l: contributor30
  reference:
    v: #contributor30
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Hasbini A
forename initials:
  v: A

contributor:
  l: contributor31
  reference:
    v: #contributor31
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Bousquet G
forename initials:
  v: G

contributor:
  l: contributor32
  reference:
    v: #contributor32
  type:
    v: Practitioner
    l: Practitioner
  display:
    v: Soulie M
forename initials:
  v: M